drugset
drugset / Trial / NCT00315913

Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor

NCT00315913 ↗

Phase 2 Withdrawn University of California, Irvine
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether propranolol is better than oxytocin for the treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by women receiving prolonged oxytocin versus propranolol.

Timeline

Start
2004-01
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 2 mg Intravenous

Indications

dystocia